This would further imply that increasing 3222401L13Rik expression or strengthening the interaction of 3222401L13Rik and Npas3 in early aging processes or at the onset of neurodegenerative diseases such as AD could be a potential clinical option to delay the onset of neuronal dysfunction. The gene discussed is NPAS3; the disease is Alzheimer disease.